Support
DONATE
DONATE

Neuroendocrine Cancer Symptoms Awareness Card

Apr 19, 2023

Neuroendocrine Cancer UK’s GP Awareness Cards are an essential tool for raising awareness of Neuroendocrine Cancer and encouraging early diagnosis. By ordering and distributing these cards to your local clinics and GP practices, you can help make a real difference in the fight against this cancer.

Our aim is to ensure that more people get diagnosed and treated early, and you can play a part in achieving this goal. Ordering and sharing these cards is a simple yet effective way to spread awareness of Neuroendocrine Cancer and save lives.

To order the GP Awareness Cards, simply visit our website and fill out the form. It only takes a few minutes, but the impact of your actions could be enormous.

Don’t hesitate, join us in the fight against Neuroendocrine Cancer and make a difference today! Order your GP Awareness Cards now.

 

References: national incidence figures CRUK : https://www.cancerresearchuk.org/health-professional/cancer-statistics/incidence 371% date : source NCUK (White et al awaiting publication) 2nd primaries: White, B. Incidence of Neuroendocrine Neoplasms reported in England 2015 – 2017. UKINETs 17th Annual Conference – 2 December 2019. White et al (2020) Metachronous Neuroendocrine Neoplasms in England 2013–2015. UKI NETS 18th National Conference Online 30 November – 3 December 2020: P6 Poster presentation/abstract. Genus et al (2017) Metachronous primary cancers in neuroendocrine tumour patients. Endocrine Abstracts (2017) 52 P13 Habal et al (2000) Gastrointestinal carcinoid tumors and second primary malignancies. J Surg Oncol. 75(4):310-6. multiple GP visits Basuroy et al (2018) Presenting Symptoms and Delay in Diagnosis of Gastrointestinal and Pancreatic Neuroendocrine Tumours. Neuroendocrinology; 107(1):42-49. Basuroy et al (2018) Delays and routes to diagnosis of neuroendocrine tumours. BMC Cancer: 18(1):1122

HCP Claire Gilligan – Claire handles the blood tests after a patient has PRRT (Peptide Receptor Radionuclide Therapy) and has helped Alderley Edge Medical Practice in Cheshire, understand more about Neuroendocrine Cancer.

We have reached 26,000 GPs with our education materials about Neuroendocrine Cancer to help raise awareness of the disease! Thank you to all who have helped us achieve this.

Thank you.